Showing results (201-210 of 4,153) with videos related to
Sort By:
Pageof 416
Regulatory Peptides|June 11, 1992
Influence of VIP on the number of enterochromaffin and mucosal mast cells in the colon of the ratM I Ledesma de Paolo, F P Celener Gravelle, D Celener, et al.Regulatory Peptides|June 11, 1992
Immunodetection of secretogranin II in animal and human tissues by new monoclonal antibodiesM Pelagi, A Zanini, A Gasparri, et al.Regulatory Peptides|July 2, 1992
Cardiovascular and respiratory actions of pituitary adenylate cyclase-activating polypeptidesY Ishizuka, K Kashimoto, T Mochizuki, et al.Regulatory Peptides|August 13, 1992
Difference between the antisecretory mechanisms of opioids and the somatostatin analogue octreotide in cholera toxin-induced small intestinal secretion in the ratA SjöqvistRegulatory Peptides|October 13, 1992
High potency of a new bombesin antagonist (RC-3095) in inhibiting serum gastrin levels; comparison of different routes of administrationJ Pinski, T Yano, Z Rekasi, et al.Regulatory Peptides|July 2, 1992
Demonstration of [125I]VIP binding sites and effects of VIP on cAMP-formation in rat insulinoma (RINm5F and RIN14B) cellsM Andersson, R Sillard, A RökaeusRegulatory Peptides|August 13, 1992
Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptideA Absood, D Chen, Z Y Wang, et al.Regulatory Peptides|April 29, 1992
Parasympathetic NANC-secretion of saliva in the mink, and effects of substance P and VIPG Tobin, J EkströmRegulatory Peptides|March 5, 1992
Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates cyclic AMP formation as well as peptide output of cultured pituitary melanotrophs and AtT-20 corticotrophsB Koch, B Lutz-BucherRegulatory Peptides|February 18, 1992
Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of researchA ArimuraPageof 416